By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

The Stanley Medical Research Institute 

5430 Grosvenor Lane, Suite 200

Bethesda  Maryland  20814  U.S.A.
Phone: 301-571-0760 Fax: 301-571-0769


SEARCH JOBS








Company News
Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program 4/26/2012 7:50:02 AM
Omeros Corporation Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program 1/28/2009 11:17:24 AM
Memory Pharmaceuticals (MEMY) Announces Agreement With The Stanley Medical Research Institute For The Development Of MEM 1003 For Bipolar Disorder 12/20/2005 10:48:18 AM
Repligen Corporation (RGEN) And The Stanley Medical Research Institute Expand Development Agreement For Uridine For Bipolar Depression 10/21/2005 12:20:31 PM
Novasite Pharmaceuticals And The Stanley Medical Research Institute Announce Alliance To Discover Novel Allosteric Modulator Drugs For Schizophrenia10/19/2005 5:12:22 PM
Potomac Pharma Inc. Announces Investment From The Stanley Medical Research Institute10/19/2005 5:11:02 PM
Saegis Pharmaceuticals Receives $2 Million Investment From The Stanley Medical Research Institute10/19/2005 5:09:49 PM
//-->